These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 20005316

  • 1. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC, Chevrel G, Schott AM, Garnero P.
    Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
    [Abstract] [Full Text] [Related]

  • 2. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 3. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P, Schott AM, Prockop D, Chevrel G.
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 7. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD.
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [Abstract] [Full Text] [Related]

  • 8. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
    Garnero P, Peterfy C, Zaim S, Schoenharting M.
    Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
    [Abstract] [Full Text] [Related]

  • 10. Urinary markers of altered collagen metabolism in fibromyalgia patients.
    Ribel-Madsen S, Christgau S, Gronemann ST, Bartels EM, Danneskiold-Samsøe B, Bliddal H.
    Scand J Rheumatol; 2007 Sep; 36(6):470-7. PubMed ID: 18092271
    [Abstract] [Full Text] [Related]

  • 11. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E.
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [Abstract] [Full Text] [Related]

  • 12. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
    Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM.
    J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
    [Abstract] [Full Text] [Related]

  • 13. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Echevarría M, Ros I, Ballesta AM, Muñoz-Gómez J.
    J Bone Miner Metab; 2002 May; 20(2):116-20. PubMed ID: 11862534
    [Abstract] [Full Text] [Related]

  • 14. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M, Schulz M, Brenner RE, Bushart GB, Teller WM, Vetter U.
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [Abstract] [Full Text] [Related]

  • 15. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 16. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 17. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 18. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
    Roschger P, Fratzl-Zelman N, Misof BM, Glorieux FH, Klaushofer K, Rauch F.
    Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
    [Abstract] [Full Text] [Related]

  • 19. Bone turnover markers in patients with osteogenesis imperfecta.
    Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S.
    Bone; 2004 Jun; 34(6):1013-6. PubMed ID: 15193547
    [Abstract] [Full Text] [Related]

  • 20. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H.
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.